KUALA LUMPUR (Dec 14): Ta Win Holdings Bhd will be acquiring a 32.5% stake in pharmaceutical company Royce Pharma Manufacturing Sdn Bhd for RM20.85 million.
In a bourse filing, the group said its wholly-owned subsidiary Ta Win Copper Biohealth Sdn Bhd (TWC Biohealth) inked a share sale agreement with Poly Lab Sdn Bhd for the acquisition of a 22.8% or 2.74 million share stake in Royce Pharma for RM14.64 million.
At the same time, it signed a subscription agreement with Royce Pharma and the latter’s shareholders Poly Lab and Jelita Serbaneka Sdn Bhd for the subscription of 1.16 million new shares, which represent 9.8% of Royce Pharma’s enlarged share capital, at RM6.21 million.
From left are Royce Pharma Manufacturing president Zainal Ariff Tan Sri Mahmood and group deputy president Datuk Chandrasekar Suppiah; Deputy Human Resources Minister Awang Hashim Awang Hashim while Ta Win Holdings was presented by its group managing director Datuk Seri Ngu Tieng Ung and executive director Tan Poo Chuan.
’s subsidiary is venturing into the pharmaceutical industry through its RM20.85mil investment in Royce Pharma Manufacturing Sdn Bhd.
It said in a statement on Monday its healthcare arm Ta Win Copper Biohealth Sdn Bhd (TWCB) agreed to acquire a 32.5% stake in Royce Pharma, marking the first investment in the pharmaceutical industry.